|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/395 | |||
| C12P 21/08 | |||
| C12N 5/07 | |||
| G01N 33/569 | |||
| C07K 16/22 | |||
| C07K 16/28 |
| (11) | Number of the document | 3104880 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15748950.1 |
| Date of filing the European patent application | 2015-02-11 | |
| (97) | Date of publication of the European application | 2016-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/015320 |
| Date | 2015-02-11 |
| (87) | Number | WO 2015/123241 |
| Date | 2015-08-20 |
| (30) | Number | Date | Country code |
| 201461939804 P | 2014-02-14 | US |
| (72) |
Chi, Andrew S., US
|
| (73) |
MacroGenics, Inc.,
9704 Medical Center Drive, Rockville, MD 20850,
US
|
| (54) | IMPROVED METHODS FOR THE TREATMENT OF VASCULARIZING CANCERS |
| IMPROVED METHODS FOR THE TREATMENT OF VASCULARIZING CANCERS |